3S Corporation — Cyclophosphamide Exporter Profile
Indian Pharmaceutical Exporter · #9 for Cyclophosphamide · $171.1K export value · DGFT Verified
3S Corporation is the #9 Indian exporter of Cyclophosphamide with $171.1K in export value and 35 verified shipments. 3S Corporation holds a 0.9% market share in Cyclophosphamide exports across 5 countries. The company exports 13 pharmaceutical products worth $505.4K across 4 therapeutic categories.
3S Corporation — Cyclophosphamide Export Profile: Buyers & Destinations
Where Does 3S Corporation Export Cyclophosphamide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TURKEY | $163.2K | 19 | 95.4% |
| NIGERIA | $7.5K | 8 | 4.4% |
| KENYA | $376 | 4 | 0.2% |
| PAKISTAN | $12 | 1 | 0.0% |
| ANTIGUA | $0 | 3 | 0.0% |
3S Corporation exports Cyclophosphamide to 5 countries. The largest destination is TURKEY accounting for 95.4% of 3S Corporation's Cyclophosphamide shipments, followed by NIGERIA (4.4%) and KENYA (0.2%). These destinations reflect 3S Corporation's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cyclophosphamide from 3S Corporation?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| FOR THE ORDER OF | NIGERIA | $138.3K | 18 |
| FOR THE ORDER OF ,. ., | TURKEY | $15.3K | 2 |
| GREAT GRACE LTD | NIGERIA | $2.3K | 2 |
| FOR THE ORDER OF GREAT GRACE NIG LIMITED | NIGERIA | $1.7K | 2 |
| TO THE ORDER | NIGERIA | $1.2K | 1 |
| FOR THE ORDER OF , . | KENYA | $376 | 4 |
| FOR THE ORDER OF ..... | ANTIGUA | $0 | 3 |
3S Corporation supplies Cyclophosphamide to 7 buyers globally. The largest buyer is FOR THE ORDER OF (NIGERIA), followed by FOR THE ORDER OF ,. ., (TURKEY) and GREAT GRACE LTD (NIGERIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cyclophosphamide Export Value and How Much Does 3S Corporation Contribute?
India exported $4.6M worth of Cyclophosphamide through 2,113 shipments from 259 suppliers to 114 countries, serving 518 buyers globally. 3S Corporation contributes $171.1K to this total, accounting for 0.9% of India's Cyclophosphamide exports. 3S Corporation ships Cyclophosphamide to 5 countries through 7 buyers.
What Is the Average Shipment Value for 3S Corporation's Cyclophosphamide Exports?
3S Corporation's average Cyclophosphamide shipment value is $4.9K per consignment, based on 35 shipments totaling $171.1K. The largest destination is TURKEY (95.4% of 3S Corporation's Cyclophosphamide exports).
How Does 3S Corporation Compare to Other Indian Cyclophosphamide Exporters?
3S Corporation ranks #9 among 259 Indian Cyclophosphamide exporters with a 0.9% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($1.1M), ALEMBIC PHARMACEUTICALS LIMITED ($850.4K), CIPLA LIMITED ($550.0K). 3S Corporation processed 35 shipments to 5 destination countries.
What Cyclophosphamide Formulations Does 3S Corporation Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CYCLOPHOSPHAMIDE INJ IP 500MG | $37.5K | 5 |
| CYCLOPHOSPHAMIDE INJECTION IP 1 G | $34.0K | 3 |
| CYCLOPHOSPHAMIDE INJECTION IP 1000 MG | $30.0K | 2 |
| CYCLOPHOSPHAMIDE INJ IP 500 | $18.1K | 6 |
| CYCLOPHOSPHAMIDE INJECTION IP 1000MG | $17.0K | 4 |
| CYCLOPHOSPHAMIDE INJECTION IP 1000MGVLS | $15.1K | 1 |
| CYCLOPHOSPHAMIDE INJ IP 500MGVLS | $11.5K | 1 |
| PHOXELON 500 MG INJ-CYCLOPHOSPHAMIDE INJECTION POWDER FOR SOLUTION PARENTERAL 500MG BT-OL0796,OL0795 M-8/24 E-7/26 | $1.9K | 1 |
| CYCLOPHOSPHAMIDE INJ IP 500MG Batch:NO-23FCP0523GCP0323GCP04 MANUFACTURING -JUN-23JUL23EXPDT-MAY-25JUN-25 | $1.5K | 1 |
| CYCLOPHOSPHAMIDE INJ IP 500MG CYCLOSTED | $1.2K | 1 |
3S Corporation exports 20 distinct Cyclophosphamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CYCLOPHOSPHAMIDE INJ IP 500MG with 5 shipments worth $37.5K.
Regulatory Requirements: Exporting Cyclophosphamide to Key Markets
What 3S Corporation must comply with to export Cyclophosphamide to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does 3S Corporation Compare to Nearest Cyclophosphamide Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | KWALITY PHARMACEUTICALS LIMITED | $235.6K | 19 | 4 | $12.4K |
| 8 | VAMA LIFECARE PRIVATE LIMITED | $204.4K | 21 | 6 | $9.7K |
| 9 | 3S CORPORATION ★ | $171.1K | 35 | 5 | $4.9K |
| 10 | VIVALIA REMEDIES PRIVATE LIMITED | $147.8K | 4 | 1 | $37.0K |
| 11 | GETWELL PHARMA INDIA PRIVATE LIMITED | $139.9K | 71 | 13 | $2.0K |
3S Corporation ranks #9 among 259 Indian Cyclophosphamide exporters. Average shipment value of $4.9K compared to the market average of $17.9K. The closest competitors by value are KWALITY PHARMACEUTICALS LIMITED and VAMA LIFECARE PRIVATE LIMITED.
Which Indian Ports Ship Cyclophosphamide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 561 | 26.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 442 | 20.9% |
| DELHI AIR | 246 | 11.6% |
| DELHI AIR CARGO ACC (INDEL4) | 189 | 8.9% |
| Bombay Air | 154 | 7.3% |
| Delhi Air | 51 | 2.4% |
| Bombay Air Cargo | 51 | 2.4% |
| HYDERABAD AIR | 36 | 1.7% |
About 3S Corporation
3S Corporation exports 13 products worth $505.4K. Beyond Cyclophosphamide, top products include Warfarin, Procarbazine, Daunorubicin, Mefloquine, Carfilzomib. View the complete 3S Corporation profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cyclophosphamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cyclophosphamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: 3S Corporation matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 35 individual customs records matching 3S Corporation exporting Cyclophosphamide, covering 20 formulations to 5 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 114+ countries, 518+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cyclophosphamide Export Data from 3S Corporation
Access shipment-level details, pricing data, buyer connections, and competitive analysis for 3S Corporation's Cyclophosphamide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
3S Corporation
Full Company Profile →
13 products · $505.4K total trade · 4 categories
Cyclophosphamide Stats
Company Overview
Top Products by 3S Corporation
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for 3S Corporation.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cyclophosphamide. For current shipment-level data, contact TransData Nexus.